Form 4 Tracker
Century Therapeutics, Inc.
IPSC

38 insider filings · Latest: Sep 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 4, 2024Nov 4 8:52 PMFarid Adrienne
Proposed Sale
1,033$1.23$1.3K—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 9, 2026Sep 10 9:48 PMJoseph TruittDirector
Grant/Award
148,000$2.03148,000(D)

View →

Jun 11, 2026Jun 12 9:08 PMAlessandro RivaDirector
Grant/Award
74,000$2.2474,000(D)

View →

Jun 11, 2026Jun 12 9:07 PMDaphne QuimiDirector
Grant/Award
74,000$2.2474,000(D)

View →

Jun 11, 2026Jun 12 9:06 PMMartin Patrick MurphyDirector
Grant/Award
74,000$2.2474,000(D)

View →

Jun 11, 2026Jun 12 9:05 PMHan Myung LeeDirector
Grant/Award
74,000$2.2474,000(D)

View →

Jun 11, 2026Jun 12 9:05 PMKimberly BlackwellDirector
Grant/Award
74,000$2.2474,000(D)

View →

Dec 9, 2025Apr 10 9:07 PMMartin Patrick MurphyDirector
Grant/Award
88,000$0.59288,000(D)

View →

Feb 2, 2026Feb 4 9:22 PMBrent PfeiffenbergerDirector, President and CEO
Grant/Award
945,000$1.84945,000(D)

View →

Feb 2, 2026Feb 4 9:19 PMGregory RussottiTitle: Chief Technology and Manufacturing Officer
Grant/Award
265,000$1.84265,000(D)

View →

Feb 2, 2026Feb 4 9:15 PMChad CowanChief Scientific Officer
Grant/Award
265,000$1.84265,000(D)

View →

Feb 2, 2026Feb 4 9:12 PMDouglas CarrSVP Finance & Operations
Grant/Award
225,000$1.84225,000(D)

View →